Article thumbnail

In Vivo Gene Knockdown in Rat Dorsal Root Ganglia Mediated by Self-Complementary Adeno-Associated Virus Serotype 5 Following Intrathecal Delivery

By Qinghao Xu, Beverly Chou, Bethany Fitzsimmons, Atsushi Miyanohara, Veronica Shubayev, Camila Santucci, Michael Hefferan, Martin Marsala and Xiao-Ying Hua

Abstract

We report here in adult rat viral vector mediate-gene knockdown in the primary sensory neurons and the associated cellular and behavior consequences. Self-complementary adeno-associated virus serotype 5 (AAV5) was constructed to express green fluorescent protein (GFP) and a small interfering RNA (siRNA) targeting mammalian target of rapamycin (mTOR). The AAV vectors were injected via an intrathecal catheter. We observed profound GFP expression in lumbar DRG neurons beginning at 2-week post-injection. Of those neurons, over 85% were large to medium-diameter and co-labeled with NF200, a marker for myelinated fibers. Western blotting of mTOR revealed an 80% reduction in the lumbar DRGs (L4–L6) of rats treated with the active siRNA vectors compared to the control siRNA vector. Gene knockdown became apparent as early as 7-day post-injection and lasted for at least 5 weeks. Importantly, mTOR knockdown occurred in large (NF200) and small-diameter neurons (nociceptors). The viral administration induced an increase of Iba1 immunoreactivity in the DRGs, which was likely attributed to the expression of GFP but not siRNA. Rats with mTOR knockdown in DRG neurons showed normal general behavior and unaltered responses to noxious stimuli. In conclusion, intrathecal AAV5 is a highly efficient vehicle to deliver siRNA and generate gene knockdown in DRG neurons. This will be valuable for both basic research and clinic intervention of diseases involving primary sensory neurons

Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:3293818
Provided by: PubMed Central

Suggested articles

Citations

  1. (2009). A rapamycin-sensitive signaling pathway is essential for the full expression of persistent pain states.
  2. (2002). A system for stable expression of short interfering RNAs in mammalian cells.
  3. (2008). Activation of the neuronal extracellular signal-regulated kinase 2 in the spinal cord dorsal horn is required for complete Freund’s adjuvant-induced pain hypersensitivity.
  4. (2003). Adenoassociated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo.
  5. (2004). Altered sodium channel expression in second-order spinal sensory neurons contributes to pain after peripheral nerve injury.
  6. (2001). An automated flinch detecting system for use in the formalin nociceptive bioassay.
  7. (1992). An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat.
  8. (1996). Attenuation and recovery of nerve growth factor receptor mRNA in dorsal root ganglion neurons following axotomy.
  9. (2010). Cellular toxicity following application of adeno-associated viral vector-mediated RNA interference in the nervous system.
  10. (1997). Characterization of variables defining hindpaw withdrawal latency evoked by radiant thermal stimuli.
  11. (1976). Chronic catheterization of the spinal subarachnoid space.
  12. (2010). Comparison of AAV serotypes for gene delivery to dorsal root ganglion neurons.
  13. (2011). Comparison of adeno-associated viral vector serotypes for spinal cord and motor neuron gene delivery.
  14. (2007). Design and evaluation of small interfering RNAs that target expression of the N-methyl-D-aspartate receptor NR1 subunit gene in the spinal cord dorsal horn.
  15. (2010). Differential adeno-associated virus mediated gene transfer to sensory neurons following intrathecal delivery by direct lumbar puncture.
  16. (2001). Dorsal root ganglion neurons show increased expression of the calcium channel alpha2delta1 subunit following partial sciatic nerve injury.
  17. (2010). Efficient retrograde transport of adeno-associated virus type 8 to spinal cord and dorsal root ganglion after vector delivery in muscle.
  18. (2010). Expression and distribution of mTOR, p70S6K, 4E-BP1, and their phosphorylated counterparts in rat dorsal root ganglion and spinal cord dorsal horn.
  19. (1999). Expression of alpha2-adrenergic receptors in rat primary afferent neurones after peripheral nerve injury or inflammation.
  20. (2009). Global diffuse distribution in the brain and efficient gene delivery to the dorsal root ganglia by intrathecal injection of adeno-associated viral vector serotype 1.
  21. (2004). Intrathecal catheterization and drug delivery in the rat.
  22. (2008). Local translation in primary afferent fibers regulates nociception.
  23. (2010). Mammalian target of rapamycin in spinal cord neurons mediates hypersensitivity induced by peripheral inflammation.
  24. (2010). Mammalian target of rapamycin signaling in the spinal cord is required for neuronal plasticity and behavioral hypersensitivity associated with neuropathy in the rat.
  25. (2008). Neonatal intraperitoneal or intravenous injections of recombinant adeno-associated virus type 8 transduce dorsal root ganglia and lower motor neurons.
  26. (2004). Pharmacokinetics of intrathecal oligodeoxynucleotides.
  27. (2004). Preclinical insights into the implementation of intrathecal midazolam: a cautionary tale.
  28. (2002). Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors.
  29. (1998). Production of high-titer recombinant adenoassociated virus vectors in the absence of helper adenovirus.
  30. (1994). Quantitative assessment of tactile allodynia in the rat paw.
  31. (2003). Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo.
  32. (2004). Recent insights into the pharmacokinetics of spinal opioids and the relevance to opioid selection.
  33. (2009). Recombinant adeno-associated virus serotype 6 (rAAV2/6)-mediated gene transfer to nociceptive neurons through different routes of delivery.
  34. (2003). Redistribution of Na(V)1.8 in uninjured axons enables neuropathic pain.
  35. (2011). Robust spinal motor neuron transduction following intrathecal delivery of AAV9 in pigs. Gene Ther.
  36. (2010). Self-complementary AAV5 vector facilitates quicker transgene expression in photoreceptor and retinal pigment epithelial cells of normal mouse.
  37. (2001). Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis.
  38. (2008). Sensory neuron targeting by self-complementary AAV8 via lumbar puncture for chronic pain.
  39. (2004). siRNA Selection Server: an automated siRNA oligonucleotide prediction server.
  40. (2010). Sodium channels in normal and pathological pain.
  41. (2005). Spinal distribution and metabolism of 29-O-(2-methoxyethyl)-modified oligonucleotides after intrathecal administration in rats.
  42. (2003). Spinal nerve ligation induces transient upregulation of tumor necrosis factor receptors 1 and 2 in injured and adjacent uninjured dorsal root ganglia in the rat.
  43. (2011). Spinal phosphinositide 3-kinase-Akt-mammalian target of rapamycin signaling cascades in inflammation-induced hyperalgesia.
  44. (2004). The use of intrathecal midazolam in humans: a case study of process. Anesth Analg 98: 1536–1545. table of contents.
  45. (2006). TNFalpha-induced MMP-9 promotes macrophage recruitment into injured peripheral nerve.
  46. (2002). Upregulation of bradykinin B2 receptor expression by neurotrophic factors and nerve injury in mouse sensory neurons.
  47. (2001). Upregulation of dorsal root ganglion (alpha)2(delta) calcium channel subunit and its correlation with allodynia in spinal nerve-injured rats.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.